TMPRSS2 and prostate adenocarcinoma: Earlier, we performed an analysis of differentially expressed genes (DEGs) between groups of favorable and unfavorable prognoses for the lymph-node-negative LAPC and for the TMPRSS2–ERG-positive LAPC TCGA–PRAD cohort [35].